Comparative Evaluation of Three Phenotypic Tests—Carba NP, Modified Carba NP and Rapidec Carba NP Test for Rapid Detection of Carbapenem Resistance in Blood Culture Isolates of Escherichia coli in an ICU Setting

Background To determine the antibiotic resistance pattern, the prevalence of extended-spectrum beta-lactamases (ESBLs) and carbapenem resistance in blood culture isolates of E. coli. Further, we evaluated and compared Carba NP, Modified Carba NP and a kit-based Rapidec Carba NP test to detect carbapenem resistance rapidly. Methods Twenty-six carbapenem-resistant strains and four susceptible strains were selected. The three methods mentioned above were evaluated as per Clinical Laboratory Standards Institute (CLSI). These tests are based on biochemical detection of the hydrolysis of the beta-lactam ring of a carbapenem-imipenem, followed by the colour change of a pH indicator. Results Carba NP test was positive in 24 out of 26 isolates; the Modified Carba NP and Rapidec Carba NP tests were positive for all the isolates (26/26). All the carbapenemase non-producers (100%, 04/04) were negative. Conclusion Modified Carba NP is a more effortless and inexpensive alternative to the Carba NP test, allowing the detection of carbapenemase activity directly from bacterial cultures of Enterobacteriaceae. The test could be used in low-income countries with large reservoirs for carbapenemase producers and can be implemented in any laboratory worldwide.

[1]  K. Kooguchi,et al.  Molecular diversity of extended-spectrum β-lactamases and carbapenemases, and antimicrobial resistance , 2020, Journal of Intensive Care.

[2]  Amal Balbaa,et al.  Rapidec Carba NP for Detection of Carbapenemase-Producing Enterobacteriaceae in Clinical Isolates: Cross-Sectional Study. , 2019, Surgical infections.

[3]  J. Rodríguez-Baño,et al.  Current options for the treatment of infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in different groups of patients. , 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[4]  M. Pelisson,et al.  Escherichia coli Bloodstream Infections in Patients at a University Hospital: Virulence Factors and Clinical Characteristics , 2019, Front. Cell. Infect. Microbiol..

[5]  Ashutosh Kumar Singh,et al.  Molecular characterization of extended-spectrum β-lactamases among clinical isolates of Escherichia coli & Klebsiella pneumoniae: A multi-centric study from tertiary care hospitals in India , 2019, The Indian journal of medical research.

[6]  Ya-Ting Chang,et al.  Infections Caused by Carbapenem-Resistant Enterobacteriaceae: An Update on Therapeutic Options , 2019, Front. Microbiol..

[7]  T. Zaoutis,et al.  Treatment of extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBLs) infections: what have we learned until now? , 2018, F1000Research.

[8]  F. Codjoe,et al.  Carbapenem Resistance: A Review , 2017, Medical sciences.

[9]  B. Harish,et al.  Simple, rapid, and cost-effective modified Carba NP test for carbapenemase detection among Gram-negative bacteria , 2017, Journal of laboratory physicians.

[10]  G. Nataraj,et al.  Carba NP as a simpler, rapid, cost-effective, and a more sensitive alternative to other phenotypic tests for detection of carbapenem resistance in routine diagnostic laboratories , 2017, Journal of laboratory physicians.

[11]  B. Veeraraghavan,et al.  Strengths and limitations of various screening methods for carbapenem-resistant Enterobacteriaceae including new method recommended by clinical and laboratory standards institute, 2017: A tertiary care experience , 2017, Indian journal of medical microbiology.

[12]  A. Garg,et al.  Evaluation of the Rapidec Carba NP Test Kit for Detection of Carbapenemase-Producing Gram-Negative Bacteria , 2015, Antimicrobial Agents and Chemotherapy.

[13]  Gina K. Thomson,et al.  Comparison of the Carba NP, Modified Carba NP, and Updated Rosco Neo-Rapid Carb Kit Tests for Carbapenemase Detection , 2015, Journal of Clinical Microbiology.

[14]  M. Kamal,et al.  Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment. , 2015, Saudi journal of biological sciences.

[15]  J. Timsit,et al.  Treatment of bloodstream infections in ICUs , 2014, BMC Infectious Diseases.

[16]  S. Pournaras,et al.  Modified CLSI Extended-Spectrum β-Lactamase (ESBL) Confirmatory Test for Phenotypic Detection of ESBLs among Enterobacteriaceae Producing Various β-Lactamases , 2014, Journal of Clinical Microbiology.

[17]  Samir N. Patel,et al.  Evaluation of the Carba NP Test for Rapid Detection of Carbapenemase-Producing Enterobacteriaceae and Pseudomonas aeruginosa , 2013, Antimicrobial Agents and Chemotherapy.

[18]  P. Nordmann,et al.  Rapid Detection of Carbapenemase-producing Enterobacteriaceae , 2012, Emerging infectious diseases.

[19]  D. Nair,et al.  Extended-spectrum β-lactamases in Gram Negative Bacteria , 2010, Journal of global infectious diseases.

[20]  S. Verghese,et al.  Sequence analysis of bla CTX-M-28 , an ESBL responsible for third-generation cephalosporin resistance in Enterobacteriaceae, for the first time in India. , 2008, Indian journal of pathology & microbiology.

[21]  Jonathan R Edwards,et al.  Overview of nosocomial infections caused by gram-negative bacilli. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  R. Gaynes,et al.  NATIONAL NOSOCOMIAL INFECTIONS SURVEILLANCE S. OVERVIEW OF NOSOCOMIAL INFECTIONS CAUSED BY GRAM-NEGATIVE BACILLI , 2005 .